001     177496
005     20240229133742.0
024 7 _ |a 10.1158/1055-9965.EPI-21-0688
|2 doi
024 7 _ |a pmid:34782393
|2 pmid
024 7 _ |a 1055-9965
|2 ISSN
024 7 _ |a 1538-7755
|2 ISSN
024 7 _ |a altmetric:117032169
|2 altmetric
037 _ _ |a DKFZ-2021-02583
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Charvat, Hadrien
|b 0
245 _ _ |a Excess body fatness during early to mid-adulthood and survival from colorectal and breast cancer: a pooled analysis of five international cohort studies.
260 _ _ |a Philadelphia, Pa.
|c 2022
|b AACR
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1644585194_13689
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a 2022 Feb;31(2):325-333
520 _ _ |a Here, we explore the association between excess weight during early to mid-adulthood and survival in patients diagnosed with breast and colorectal cancer, using a pooled analysis of five cohort studies and study participants from 11 countries.Participant-level BMI trajectories were estimated by fitting a growth curve model using over 2 million repeated BMI measurements from close to 600,000 cohort participants. Cumulative measures of excess weight were derived. Data from over 23,000 breast and colorectal cancer patients were subsequently analyzed using time-to-event models for death with the date of diagnosis as start of follow-up. Study-specific results were combined through a random effect meta-analysis.We found a significant dose-response relationship (p-trend=0.013) between the average BMI during early and mid-adulthood and death from breast cancer, with a pooled hazard ratio of 1.31 (1.07, 1.60) and the time to death shortened by 16% for average BMI above 25 kg/m2 compared with average BMI less or equal to 22.5 kg/m2, respectively. Similar results were found for categories of cumulative time spent with excess weight. There was no association between excess body fatness during early to mid-adulthood and death in colorectal cancer patients.Excess body fatness during early to mid-adulthood is not only associated with an increased risk of developing cancer, but also with a lower survival in breast cancer patients.Our results emphasize the importance of public health policies aimed at reducing overweight during adulthood and inform future studies on the relationship between excess weight and cancer outcomes.
536 _ _ |a 313 - Krebsrisikofaktoren und Prävention (POF4-313)
|0 G:(DE-HGF)POF4-313
|c POF4-313
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: inrepo01.inet.dkfz-heidelberg.de
700 1 _ |a Freisling, Heinz
|0 0000-0001-8648-4998
|b 1
700 1 _ |a Noh, Hwayoung
|0 0000-0002-6978-8364
|b 2
700 1 _ |a Gaudet, Mia M
|0 0000-0002-6429-4007
|b 3
700 1 _ |a Gunter, Marc J
|0 0000-0001-5472-6761
|b 4
700 1 _ |a Cross, Amanda J
|0 0000-0002-0893-2377
|b 5
700 1 _ |a Tsilidis, Konstantinos K
|b 6
700 1 _ |a Tjønneland, Anne
|0 0000-0003-4385-2097
|b 7
700 1 _ |a Katzke, Verena
|0 P:(DE-He78)fb68a9386399d72d84f7f34cfc6048b4
|b 8
|u dkfz
700 1 _ |a Bergmann, Manuela
|0 0000-0001-5064-227X
|b 9
700 1 _ |a Agnoli, Claudia
|0 0000-0003-4472-1179
|b 10
700 1 _ |a Rylander, Charlotta
|b 11
700 1 _ |a Skeie, Guri
|0 0000-0003-2476-4251
|b 12
700 1 _ |a Jakszyn, Paula
|b 13
700 1 _ |a Rosendahl, Ann H
|0 0000-0003-0066-0677
|b 14
700 1 _ |a Sund, Malin
|0 0000-0002-7516-9543
|b 15
700 1 _ |a Severi, Gianluca
|0 0000-0001-7157-419X
|b 16
700 1 _ |a Tsugane, Shoichiro
|b 17
700 1 _ |a Sawada, Norie
|0 0000-0002-9936-1476
|b 18
700 1 _ |a Brenner, Hermann
|0 P:(DE-He78)90d5535ff896e70eed81f4a4f6f22ae2
|b 19
|u dkfz
700 1 _ |a Adami, Hans-Olov
|b 20
700 1 _ |a Weiderpass, Elisabete
|0 0000-0003-2237-0128
|b 21
700 1 _ |a Soerjomataram, Isabelle
|b 22
700 1 _ |a Arnold, Melina
|b 23
773 _ _ |a 10.1158/1055-9965.EPI-21-0688
|g p. cebp.0688.2021 -
|0 PERI:(DE-600)2036781-8
|n 2
|p 325-333
|t Cancer epidemiology, biomarkers & prevention
|v 31
|y 2022
|x 1538-7755
909 C O |p VDB
|o oai:inrepo02.dkfz.de:177496
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 8
|6 P:(DE-He78)fb68a9386399d72d84f7f34cfc6048b4
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 19
|6 P:(DE-He78)90d5535ff896e70eed81f4a4f6f22ae2
913 1 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF4-310
|0 G:(DE-HGF)POF4-313
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Krebsrisikofaktoren und Prävention
|x 0
914 1 _ |y 2021
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2021-02-02
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2021-02-02
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2021-02-02
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2022-11-10
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2022-11-10
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2022-11-10
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2022-11-10
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
|d 2022-11-10
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2022-11-10
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b CANCER EPIDEM BIOMAR : 2021
|d 2022-11-10
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2022-11-10
915 _ _ |a IF < 5
|0 StatID:(DE-HGF)9900
|2 StatID
|d 2022-11-10
920 1 _ |0 I:(DE-He78)C020-20160331
|k C020
|l C020 Epidemiologie von Krebs
|x 0
920 1 _ |0 I:(DE-He78)C070-20160331
|k C070
|l C070 Klinische Epidemiologie und Alternf.
|x 1
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)C020-20160331
980 _ _ |a I:(DE-He78)C070-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21